Memorial Sloan Kettering opens up its cancer data through OpenEvidence. Which healthcare and biotech entrepreneurs made the Forbes 400 for the first time. Persistent generic cancer drug shortages. These stories and more in this week’s Forbes Innovation…
In experiments by startup Irregular, one of Anthropic and OpenAI’s security testers, an Alibaba Qwen agent decided to retrain an entire model when it was asked to fix a basic software bug. The new behavior adds to concerns about AI models’ unpredictabi…
Markets shift when AI doom headlines surge. This analysis tracks 11 P(doom) cycles since 2023 and how investors have historically reacted across the AI stack.
Prosecutors say the former staffers traded ahead of Robinhood crypto listings, earning more than $50,000 apiece on another exchange.
A Georgia Tech study finds data centers may leave host towns’ borrowing rates largely unchanged while raising them in nearby communities.
He once mused about how he could become a billionaire. Now he’s worth more than $25 billion.
Apple alleges Meta is refusing to provide documentation in the DOJ’s iPhone monopoly suit, despite being a key player in helping the Justice Department put together its case in the first place.
Quitting social media doesn’t have to cost you clients. How one small business grew without it — and what to build instead.
OpenAI launched ChatGPT for Financial Services with Morgan Stanley and Evercore, automating research and pitchbook work long done by junior bankers.
Market euphoria has vaulted Shanghai Enflame’s cofounders into the world’s billionaire ranks, raising questions about how long the rally can last.